One of the listed companies, Silco Pharmaceuticals Limited. discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was Tk 0.16 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 0.21 paisa during the same period last year. NAV per share was Tk. 22.63 on March 31, 2024.